Litigation Details for DOW PHARMACEUTICAL SCIENCES, INC. v. TARO PHARMACEUTICALS U.S.A., INC. (D.N.J. 2016)
✉ Email this page to a colleague
DOW PHARMACEUTICAL SCIENCES, INC. v. TARO PHARMACEUTICALS U.S.A., INC. (D.N.J. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-01-12 |
| Court | District Court, D. New Jersey | Date Terminated | 2018-10-24 |
| Cause | 35:271 Patent Infringement | Assigned To | Stanley R. Chesler |
| Jury Demand | None | Referred To | Cathy L. Waldor |
| Patents | 8,288,434; 9,504,704; 9,561,208 | ||
| Link to Docket | External link to docket | ||
Details for DOW PHARMACEUTICAL SCIENCES, INC. v. TARO PHARMACEUTICALS U.S.A., INC. (D.N.J. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2016-01-11 | 1 | United States Patent No. 8,288,434 (“the ’434 patent”) arising under the United States patent laws, Title… THE PATENT IN SUIT 18. The U.S. Patent and Trademark Office (“PTO”…PTO”) issued the ’434 patent on October 16, 2012. The ’434 patent claims, inter alia, formulations of benzoyl…the ’434 patent and have the right to sue for infringement thereof. A copy of the ’434 patent is attached…Defendants. COMPLAINT FOR PATENT INFRINGEMENT Plaintiffs Dow Pharmaceutical | External link to document | |
| 2018-10-24 | 163 | to U.S. Patent No. 8,288,434 (the “’434 patent”), U.S. Patent No. 9,504,704 (the “’704 Patent”), and…and U.S. Patent No. 9,561,208 (the “’208 Patent”) and have agreed to the terms and conditions representing…2016 24 October 2018 2:16-cv-00217 830 Patent None District Court, D. New Jersey | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
